TNFα is required to confer protection in an in vivo model of classical ischaemic preconditioning

Life Sciences

Volumn 80, Issue 18, 2007, Pages 1686-1691

  Deuchar, Graeme A ^a   Opie, Lionel H ^a   Lecour, Sandrine ^a  

^a Cape Heart Centre   (South Africa)

Author keywords

Cytokines; Ischaemia; Preconditioning

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; CARDIOTONIC AGENT; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DOSE RESPONSE; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VIVO STUDY; ISCHEMIC PRECONDITIONING; LEFT CORONARY ARTERY; LEUKOCYTE ACTIVATION; MALE; NONHUMAN; RAT; REPERFUSION INJURY; STIMULATION; WESTERN BLOTTING; ANIMAL; DRUG ANTAGONISM; HEART INFARCTION; HEART INFARCTION PREVENTION; METABOLISM; PATHOLOGY; TIME; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS;

ANIMALS; CARDIOTONIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, WISTAR; RECEPTORS, TUMOR NECROSIS FACTOR; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33947540632     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.01.040     Document Type: Article

References (23)

1. Belosjorow S., Schulz R., Dorge H., Schade F.U., and Heusch G. Endotoxin and ischemic preconditioning: TNF-a concentration and myocardial infarct development in rabbits. American Journal of Physiology 277 (1999) H2470-H2475
2. Belosjorow S., Bolle I., Duschin A., Heusch G., and Schulz R. TNF-alpha antibodies are as effective as ischemic preconditioning in reducing infarct size in rabbits. American Journal of Physiology. Heart and Circulatory Physiology 284 (2003) H927-H930
3. Haudek S.B., Bryant D.D., and Giroir B.P. Differential regulation of myocardial nf kappa b following acute or chronic TNF-alpha exposure. Journal of Molecular and Cellular Cardiology 33 (2001) 1263-1271
4. Hausenloy D.J., Mocanu M.M., and Yellon D.M. Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning. Cardiovascular Research 63 (2004) 305-312
5. Hausenloy D.J., Tsang A., Mocanu M.M., and Yellon D.M. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. American Journal of Physiology. Heart and Circulatory Physiology 288 (2005) H971-H976
6. Irwin M.W., Mak S., Mann D.L., Qu R., Penninger J.M., Yan A., Dawood F., Wen W.H., Shou Z., and Liu P. Tissue expression and immunolocalization of tumor necrosis factor-α in postinfarction dysfunctional myocardium. Circulation 99 (1999) 1492-1498
7. Krieg T., Qin Q., Philipp S., Alexeyev M.F., Cohen M.V., and Downey J.M. Acetylcholine and bradykinin trigger preconditioning in the heart through a pathway that includes Akt and NOS. American Journal of Physiology. Heart and Circulatory Physiology 287 (2004) H2606-H2611
8. Kupatt C., Habazettl H., Goedecke A., Wolf D.A., Zahler S., Boekstegers P., Kelly R.A., and Becker B.F. Tumor necrosis factor-alpha contributes to ischemia- and reperfusion-induced endothelial activation in isolated hearts. Circulation Research 84 (1999) 392-400
9. Kurrelmeyer K.M., Michael L.H., Baumgarten G., Taffet G.E., Peschon J.J., Sivasubramanian N., Entman M.L., and Mann D.L. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proceedings of the National Academy of Sciences of the United States of America 97 (2000) 5456-5461
10. Lacerda L., Smith R.M., Opie L., and Lecour S. TNFalpha-induced cytoprotection requires the production of free radicals within mitochondria in C(2)C(12) myotubes. Life Sciences 79 (2006) 2194-2201
11. Lecour S., Smith R.M., Woodward B., Opie L.H., Rochette L., and Sack M.N. Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection. Journal of Molecular and Cellular Cardiology 34 (2002) 509-518
12. Lecour S., Rochette L., and Opie L. Free radicals trigger TNFalpha-induced cardioprotection. Cardiovascular Research 65 (2005) 239-243
13. Lecour S., Suleman N., Deuchar G.A., Somers S., Lacerda L., Huisamen B., and Opie L.H. Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase). Circulation 112 (2005) 3911-3918
14. Levine B., Kalman J., Mayer L., Fillit H., and Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. New England Journal of Medicine 323 (1990) 236-241
15. Mann D.L. Targeted anticytokine therapy and the failing heart. American Journal of Cardiology 95 (2005) 9C-16C (discussion 38C-40C)
16. Meldrum D.R., Cain B.S., Cleveland Jr. J.C., Meng X., Ayala A., Banerjee A., and Harken A.H. Adenosine decreases post-ischaemic cardiac TNF-alpha production: anti-inflammatory implications for preconditioning and transplantation. Immunology 92 (1997) 472-477
17. Meldrum D.R., Dinarello C.A., Shames B.D., Cleveland J.C., Cain B.S., Banerjee A., Meng X., and Harken A.H. Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-α production. Potential ultimate effector mechanisms of preconditioning. Circulation 98 (1998) II-214-II-219
18. Meldrum D.R., Meng X., Dinarello C.A., Ayala A., Cain B.S., Shames B.D., Ao L., Banerjee A., and Harken A.H. Human myocardial tissue TNFα expression following acute global ischemia in vivo. Journal of Molecular and Cellular Cardiology 30 (1998) 1683-1689
19. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
20. Ono K., Matsumori A., Shioi T., Furukawa Y., and Sasamayama S. Cytokine gene expression after myocardial infarction in rat hearts. Possible implication in left ventricular remodeling. Circulation 98 (1998) 149-156
21. Smith R.M., Lecour S., and Sack M.N. Innate immunity and cardiac preconditioning: a putative intrinsic cardioprotective program. Cardiovascular Research 55 (2002) 474-482
22. Smith R.M., Suleman N., McCarthy J., and Sack M.N. Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNFα gene. Cardiovascular Research 55 (2002) 553-560
23. Tanno M., Gorog D.A., Bellahcene M., Cao X., Quinlan R.A., and Marber M.S. Tumor necrosis factor-induced protection of the murine heart is independent of p38-MAPK activation. Journal of Molecular and Cellular Cardiology 35 (2003) 1523-1527